Travere Therapeutics, Inc. TVTX Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s interest coverage?
- Travere Therapeutics, Inc. (TVTX) reported interest coverage of -5.6× in Q1 2026.
- How has Travere Therapeutics, Inc.'s interest coverage changed year-over-year?
- Travere Therapeutics, Inc.'s interest coverage increased by 72.3% year-over-year, from -20.2× to -5.6×.
- What is the long-term trend for Travere Therapeutics, Inc.'s interest coverage?
- Over 4 years (2020 to 2025), Travere Therapeutics, Inc.'s interest coverage has grown at a -10.8% compound annual growth rate (CAGR), from -9.2× to -5.8×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.